Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial.

Kenji Kanenawa,Kyohei Yamaji,Hiroaki Tashiro,Takenori Domei,Kenji Ando,Hirotoshi Watanabe,Takeshi Kimura

Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial.

2021

Kenji Kanenawa
Kyohei Yamaji
Hiroaki Tashiro
Takenori Domei
Kenji Ando
Hirotoshi Watanabe
Takeshi Kimura

Background: We sought to evaluate the impact of patient selection for the STOPDAPT-2 trial (Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2)...

Keywords:

Emergency medicine
Single Center
Medicine
Randomized controlled trial
Percutaneous coronary intervention

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations